HUP0301873A2 - Gyógyszerkészítmény légzési nehézségek kezelésére - Google Patents

Gyógyszerkészítmény légzési nehézségek kezelésére

Info

Publication number
HUP0301873A2
HUP0301873A2 HU0301873A HUP0301873A HUP0301873A2 HU P0301873 A2 HUP0301873 A2 HU P0301873A2 HU 0301873 A HU0301873 A HU 0301873A HU P0301873 A HUP0301873 A HU P0301873A HU P0301873 A2 HUP0301873 A2 HU P0301873A2
Authority
HU
Hungary
Prior art keywords
combinating
medicament
respiratory depression
treatment
general formula
Prior art date
Application number
HU0301873A
Other languages
English (en)
Inventor
Boris Chizh
Thomas Christoph
Oswald Zimmer
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of HUP0301873A2 publication Critical patent/HUP0301873A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány tárgya legalább egy (I) általános képletű vegyület, aképletben R jelentése (a)-(f) általános képletű csoport, ahol R1, R2és R3 jelentése egymástól függetlenül hidrogénatom vagy metilcsoport,és/vagy legalább egy megfelelő enantiomer és/vagy legalább egymegfelelő diasztereomer és/vagy legalább egy megfelelő fiziológiailagalkalmazható só alkalmazása légzési nehézségek kezelésére alkalmasgyógyszerkészítmény előállítására, ahol kivételt képez a légzés alvásközbeni elakadását kiváltó légzési nehézség kezelésére alkalmasgyógyszerkészítmény. Ó
HU0301873A 2000-05-26 2001-05-05 Gyógyszerkészítmény légzési nehézségek kezelésére HUP0301873A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10025949A DE10025949A1 (de) 2000-05-26 2000-05-26 Arzneimittel zur Bekämpfung von Atemdepression
PCT/EP2001/005110 WO2001091732A2 (de) 2000-05-26 2001-05-05 Arzneimittel zur bekämpfung von atemdepression

Publications (1)

Publication Number Publication Date
HUP0301873A2 true HUP0301873A2 (hu) 2003-09-29

Family

ID=7643553

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301873A HUP0301873A2 (hu) 2000-05-26 2001-05-05 Gyógyszerkészítmény légzési nehézségek kezelésére

Country Status (12)

Country Link
US (1) US20030130203A1 (hu)
EP (1) EP1294376A2 (hu)
JP (1) JP2003534372A (hu)
AR (1) AR031584A1 (hu)
AU (2) AU6028101A (hu)
CA (1) CA2410650A1 (hu)
DE (1) DE10025949A1 (hu)
HU (1) HUP0301873A2 (hu)
MX (1) MXPA02011535A (hu)
NZ (1) NZ521440A (hu)
PE (1) PE20011327A1 (hu)
WO (1) WO2001091732A2 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
CA2518102C (en) 2003-03-04 2009-05-12 Tanabe Seiyaku Co., Ltd. Powdery preparation for nasal administration
JP2008538547A (ja) * 2005-03-09 2008-10-30 ロジャー・ウィリアムズ・ホスピタル 甲状腺刺激ホルモン放出ホルモン類縁体及び使用方法
US8343546B2 (en) * 2005-09-13 2013-01-01 Coating Place, Inc. Ion exchange resin treated to control swelling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449167C2 (de) * 1974-10-16 1984-05-24 Grünenthal GmbH, 5190 Stolberg N-Acyl-L-histidyl-L-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
NL183764C (nl) * 1974-10-16 1989-01-16 Gruenenthal Gmbh Werkwijze voor de bereiding van een geneesmiddel met psychotrope of neurotrope werking en werkwijze voor de bereiding van een histidylprolineamide-derivaat.
EP0429245B1 (en) * 1989-11-17 1996-02-07 Takeda Chemical Industries, Ltd. A therapeutic agent for central nervous diseases
PT866711E (pt) * 1995-10-24 2006-12-29 Gruenenthal Gmbh Montirelina para inibição da apneia do sono
WO1998051309A1 (en) * 1997-05-16 1998-11-19 The Trustees Of The University Of Pennsylvania Use of serotonin agonists to alleviate disordered breathing episodes in a mammal

Also Published As

Publication number Publication date
US20030130203A1 (en) 2003-07-10
MXPA02011535A (es) 2003-06-06
EP1294376A2 (de) 2003-03-26
NZ521440A (en) 2004-09-24
WO2001091732A3 (de) 2002-04-18
AU6028101A (en) 2001-12-11
DE10025949A1 (de) 2001-11-29
AR031584A1 (es) 2003-09-24
WO2001091732A2 (de) 2001-12-06
JP2003534372A (ja) 2003-11-18
AU2001260281B2 (en) 2005-01-27
PE20011327A1 (es) 2002-01-26
CA2410650A1 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
NO20052914L (no) Terapeutiske forbindelser
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
SE0104334D0 (sv) Therapeutic agents
UA83233C2 (ru) Замещенный 2-аминотетралин для лечения депрессии
HUP0100437A2 (hu) Szabályzott felszabadulású gyógyszerkészítmény tolterodin adagolására
NO20050569L (no) Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
IL171977A (en) Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
NO20065880L (no) 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor
HUP0303639A2 (hu) Új amlodipin-kamzilát és eljárás annak előállítására
MXPA05005790A (es) Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central.
HUP0104963A2 (hu) Bőrbetegségek kezelésére szolgáló készítmények
DE69227583T2 (de) Arylmorpholine, herstellung und verwendung
DE502004002171D1 (de) Verwendung von 2-amino-2h-chinazolin-derivaten zur herstellung von therapeutischen mitteln
HUP0301873A2 (hu) Gyógyszerkészítmény légzési nehézségek kezelésére
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
DE60128911D1 (de) Verwendung von l-threo-methylphenidat zur herstellung eines medikamentes zur behandlung von psychischen erkrankungen
DE602005017629D1 (de) Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis
WO2008032222A3 (en) Treatment of vertigo with acetyl-l-leucine
BR0009080A (pt) Método de tratamento da apnéia do sono
HUP0201878A2 (hu) Sibutramint és orlistatot tartalmazó gyógyszerkészítmények
WO2004043982A3 (fr) Nouveaux derives amphiphiles de l'alpha-c-phenyl-n-tert-butyl nitrone
RU2004112422A (ru) Роувастатин в преддеменционных состояниях
HUP0402298A2 (hu) Dezoxipeganin alkalmazása klinikai depresszió kezelésére

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees